Nyumbani › Saratani ya Kifuko cha Nyongo
Majaribio ya kliniki ya Saratani ya Kifuko cha Nyongo yanayovutia washiriki nchini Marekani
Masomo 14 ya Saratani ya Kifuko cha Nyongo yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Baldwin Park, CAUtafiti 4
- New York City, NYUtafiti 4
- Cleveland, OHUtafiti 4
- Nashville, TNUtafiti 4
- Oklahoma City, OKUtafiti 3
- Louisville, KYUtafiti 3
- Seattle, WAUtafiti 3
- Dallas, TXUtafiti 3
- Birmingham, ALUtafiti 3
- Philadelphia, PAUtafiti 3
- Houston, TXUtafiti 3
- Pittsburgh, PAUtafiti 3
- Los Angeles, CAUtafiti 3
- Portland, ORUtafiti 3
- Boston, MAUtafiti 3
Kwa jimbo
- AlabamaUtafiti 3
- CaliforniaUtafiti 9
- ColoradoUtafiti 4
- ConnecticutUtafiti 3
- FloridaUtafiti 8
- IllinoisUtafiti 4
- KentuckyUtafiti 3
- MassachusettsUtafiti 4
- MichiganUtafiti 3
- MinnesotaUtafiti 3
- New YorkUtafiti 5
- North CarolinaUtafiti 4
- OhioUtafiti 7
- OklahomaUtafiti 3
- OregonUtafiti 3
- PennsylvaniaUtafiti 4
- TennesseeUtafiti 4
- TexasUtafiti 5
- WashingtonUtafiti 3
- WisconsinUtafiti 3
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07059884A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06760819A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07265674A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07221253DESTINY-PANTUMOUR04
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 130 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07124000Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
InaajiriHatua 2
Umri 19 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07146646Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06282575Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07780838Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT05285358Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
InaajiriHatua 1/2
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT05000294Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT06101277Integrated Cancer Repository for Cancer Research
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 19 hadi 110 · Jinsia zote · Imesasishwa 29 Jun 2026 · NCT02012699Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Inaajiri
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 20 Feb 2026 · NCT04907643Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.